Heerma Peterinsider trades
In SEC Form 4 filings, Heerma Peter is listed as EVP, CHIEF COMMERCIAL OFFICER of Travere Therapeutics, Inc. (TVTX). In the last 90 days, Heerma Peter sold $17.86M of Travere Therapeutics, Inc. (TVTX) on the open market and bought none. All 7 sales were reported under a 10b5-1 trading plan.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| TVTXTravere Therapeutics, Inc. | EVP, CHIEF COMMERCIAL OFFICER | 21 | Sep 17 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-17
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| TVTXTravere Therapeutics, Inc. | Sep 17 | Sep 17 | M | 8,282 | $22.40 | $185,517 | 125,348 | Yes | Form 4 |
| TVTXTravere Therapeutics, Inc. | Sep 17 | Sep 17 | S | 8,282 | $65.07 | Sale −$538,917 | 117,066 | Yes | Form 4 |
| TVTXTravere Therapeutics, Inc. | Sep 17 | Sep 17 | M · derivative | 8,282 | $22.40 | $185,517 | 44,837 | Yes | Form 4 |
| TVTXTravere Therapeutics, Inc. | Sep 16 | Sep 17 | M | 100,000 | $11.25 | $1,125,000 | 217,066 | Yes | Form 4 |
| TVTXTravere Therapeutics, Inc. | Sep 16 | Sep 17 | M | 55,000 | $15.46 | $850,300 | 272,066 | Yes | Form 4 |
| TVTXTravere Therapeutics, Inc. | Sep 16 | Sep 17 | M | 17,717 | $26.88 | $476,233 | 289,783 | Yes | Form 4 |
| TVTXTravere Therapeutics, Inc. | Sep 16 | Sep 17 | S | 93,604 | $63.25 | Sale −$5,920,182 | 196,179 | Yes | Form 4 |
| TVTXTravere Therapeutics, Inc. | Sep 16 | Sep 17 | S | 79,113 | $63.65 | Sale −$5,035,906 | 117,066 | Yes | Form 4 |
| TVTXTravere Therapeutics, Inc. | Sep 16 | Sep 17 | M · derivative | 100,000 | $11.25 | $1,125,000 | not reported | Yes | Form 4 |
| TVTXTravere Therapeutics, Inc. | Sep 16 | Sep 17 | M · derivative | 55,000 | $15.46 | $850,300 | not reported | Yes | Form 4 |
| TVTXTravere Therapeutics, Inc. | Sep 16 | Sep 17 | M · derivative | 17,717 | $26.88 | $476,233 | 500 | Yes | Form 4 |
| TVTXTravere Therapeutics, Inc. | Sep 15 | Sep 17 | M | 39,283 | $26.88 | $1,055,927 | 181,349 | Yes | Form 4 |
| TVTXTravere Therapeutics, Inc. | Sep 15 | Sep 17 | M | 1,381 | $22.40 | $30,934 | 182,730 | Yes | Form 4 |
| TVTXTravere Therapeutics, Inc. | Sep 15 | Sep 17 | M | 36,526 | $8.93 | $326,177 | 219,256 | Yes | Form 4 |
| TVTXTravere Therapeutics, Inc. | Sep 15 | Sep 17 | S | 71,938 | $62.05 | Sale −$4,463,875 | 147,318 | Yes | Form 4 |
| TVTXTravere Therapeutics, Inc. | Sep 15 | Sep 17 | S | 27,421 | $62.59 | Sale −$1,716,379 | 119,897 | Yes | Form 4 |
| TVTXTravere Therapeutics, Inc. | Sep 15 | Sep 17 | S | 1,400 | $63.65 | Sale −$89,113 | 118,497 | Yes | Form 4 |
| TVTXTravere Therapeutics, Inc. | Sep 15 | Sep 17 | S | 1,431 | $65.31 | Sale −$93,458 | 117,066 | Yes | Form 4 |
| TVTXTravere Therapeutics, Inc. | Sep 15 | Sep 17 | M · derivative | 39,283 | $26.88 | $1,055,927 | 18,217 | Yes | Form 4 |
| TVTXTravere Therapeutics, Inc. | Sep 15 | Sep 17 | M · derivative | 1,381 | $22.40 | $30,934 | 53,119 | Yes | Form 4 |
| TVTXTravere Therapeutics, Inc. | Sep 15 | Sep 17 | M · derivative | 36,526 | $8.93 | $326,177 | 28,474 | Yes | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.